(Q38472686)

3 September 2017

title

Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype (English)

1 reference

3 September 2017

1 reference

Jarvis EM

1

1 reference

3 September 2017

Kirk JA

series ordinal

2

1 reference

3 September 2017

Clarke CL

series ordinal

3

1 reference

3 September 2017

publication date

1 March 1998

1 reference

Cancer Genetics and Cytogenetics

3 September 2017

published in

1 reference

3 September 2017

volume

101

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

109-115

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Histoprognostic grade in BRCA1-associated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Growth retardation and tumour inhibition by BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

BRCA1 is secreted and exhibits properties of a granin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Aberrant subcellular localization of BRCA1 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

BRCA1 protein products: Antibody specificity…

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Location of BRCA1 in human breast and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Risk factors for breast cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Estrogen receptor variants in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

Ki-67 immunostaining in human breast tumors and its relationship to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2897%2900267-7

7 January 2021

10.1016/S0165-4608(97)00267-7

Identifiers

DOI

1 reference

3 September 2017

1 reference